ConductScience.org, home

Paper11752178

Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease.

Fernandez M and 3 others. J Virol, 2002. Cited by 198 papers, by iCite.

Cite this record

ConductScience Library. Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease. Papers, record 11752178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11752178

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease.
PubMed
Journal
J Virol
PubMed
Year
2002
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
198
iCite
Relative citation ratio, by iCite
3.61
iCite
Revised in PubMed
2021-10-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fernandez MMarilyn
2Porosnicu MMercedes
3Markovic DDubravka
4Barber GNGlen N

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic EngineeringMajor topic
Genetic TherapyMajor topic
NeoplasmsMajor topic
Vesicular stomatitis Indiana virusMajor topic
Animals
Base Sequence
Cells, Cultured
Cricetinae
DNA, Recombinant
Enzyme-Linked Immunosorbent Assay
Genetic Vectors
Interferons
Interleukin-4
Lung Neoplasms
Mammary Neoplasms, Animal
Melanoma
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Molecular Sequence Data
Neoplasm Transplantation
Survival Analysis
Thymidine Kinase
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01CA194404NIH

Source NIH RePORTER

Download CSV of grants

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17753828Recombinant vesicular stomatitis viruses from DNA.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7753828PubMed
211152493Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.J Virol2001https://conductscience.org/library/papers/11152493PubMed
311185959Vesicular stomatitis virus (VSV) therapy of tumors.IUBMB Life2000https://conductscience.org/library/papers/11185959PubMed
411029795Interleukin-4 and breast cancer.Breast Cancer2000https://conductscience.org/library/papers/11029795PubMed
511228419Stability and commitment in T helper cell development.Curr Opin Immunol2001https://conductscience.org/library/papers/11228419PubMed
611238874Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or myc function and involves the induction of apoptosis.J Virol2001https://conductscience.org/library/papers/11238874PubMed
711390612Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development.J Virol2001https://conductscience.org/library/papers/11390612PubMed
811279246Virally induced lytic cell death elicits the release of immunogenic GRP94/gp96.J Biol Chem2001https://conductscience.org/library/papers/11279246PubMed
911551502An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.Cell2001https://conductscience.org/library/papers/11551502PubMed
101109790Biological behavior of malignant melanoma cells correlated to their survival in vivo.Cancer Res1975https://conductscience.org/library/papers/1109790PubMed
111918995
Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
J Immunol1991https://conductscience.org/library/papers/1918995PubMed
121636093An eosinophil-dependent mechanism for the antitumor effect of interleukin-4.Science1992https://conductscience.org/library/papers/1636093PubMed
138396259Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8396259PubMed
148607030In situ use of suicide genes for cancer therapy.Semin Oncol1996https://conductscience.org/library/papers/8607030PubMed
158832876An adenovirus mutant that replicates selectively in p53-deficient human tumor cells.Science1996https://conductscience.org/library/papers/8832876PubMed
169080117Herpes simplex virus thymidine kinase/ganciclovir-mediated killing of tumor cell induces tumor-specific cytotoxic T cells in mice.Cancer Gene Ther1997https://conductscience.org/library/papers/9080117PubMed
179298897Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection.Cell1997https://conductscience.org/library/papers/9298897PubMed
1810233930Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus.J Virol1999https://conductscience.org/library/papers/10233930PubMed
1910411938Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10411938PubMed
2010637559Suicide genes: past, present and future perspectives.Immunol Today2000https://conductscience.org/library/papers/10637559PubMed

See all 28 referencesDownload CSV of references

Cited by130

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 198 citations.

PMIDTitleJournalYearIn PapersSource
42644627Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome.Cancer Immunol Res2026https://conductscience.org/library/papers/42644627PubMed
42137594Low-density lipoproteins in human serum competitively inhibit the binding and entry of vesicular stomatitis virus.Mol Ther Adv2026https://conductscience.org/library/papers/42137594PubMed
41907187Conditional Stat2 Knockout Mice as a Platform for Modeling Human Diseases.Immuno2026https://conductscience.org/library/papers/41907187PubMed
41714430CircRNA expression profiling in H1N1-infected primary human tracheobronchial epithelial cells identifies candidate immune-related circRNAs validated in A549 cells.Arch Virol2026https://conductscience.org/library/papers/41714430PubMed
39877014Recombinant VSVs: A Promising Tool for Virotherapy.Acta Naturae2024https://conductscience.org/library/papers/39877014PubMed
39861805Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations.Viruses2024https://conductscience.org/library/papers/39861805PubMed
39811672ZFAND6 promotes TRAF2-dependent mitophagy to restrain cGAS-STING signaling.iScience2025https://conductscience.org/library/papers/39811672PubMed
39772239Vesicular Stomatitis Virus: Insights into Pathogenesis, Immune Evasion, and Technological Innovations in Oncolytic and Vaccine Development.Viruses2024https://conductscience.org/library/papers/39772239PubMed
39138205Hippo signaling pathway regulates Ebola virus transcription and egress.Nat Commun2024https://conductscience.org/library/papers/39138205PubMed
39062169Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer.Biomedicines2024https://conductscience.org/library/papers/39062169PubMed
38937436Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response.Nat Commun2024https://conductscience.org/library/papers/38937436PubMed
38045348Chimerization of the Anti-Viral CD8+ T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy.Res Sq2023https://conductscience.org/library/papers/38045348PubMed
37383986Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina.Front Virol2023https://conductscience.org/library/papers/37383986PubMed
35837384Immunovirotherapy Based on Recombinant Vesicular Stomatitis Virus: Where Are We?Front Immunol2022https://conductscience.org/library/papers/35837384PubMed
35062207Untargeted Lipidomics of Vesicular Stomatitis Virus-Infected Cells and Viral Particles.Viruses2021https://conductscience.org/library/papers/35062207PubMed
34761105Chandipura virus induces cell death in cancer cell lines of human origin and promotes tumor regression in vivo.Mol Ther Oncolytics2021https://conductscience.org/library/papers/34761105PubMed
34220783In vitro Studies and Clinical Observations Imply a Synergistic Effect Between Epstein-Barr Virus and Dengue Virus Infection.Front Microbiol2021https://conductscience.org/library/papers/34220783PubMed
32833351The Propagation, Quantification, and Storage of Vesicular Stomatitis Virus.Curr Protoc Microbiol2020https://conductscience.org/library/papers/32833351PubMed
32156810Barrier-to-Autointegration Factor 1 Protects against a Basal cGAS-STING Response.mBio2020https://conductscience.org/library/papers/32156810PubMed
31410657Investigating Macrophages Plasticity Following Tumour-Immune Interactions During Oncolytic Therapies.Acta Biotheor2019https://conductscience.org/library/papers/31410657PubMed

See all 130 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11752178

GET https://conductscience.org/api/papers/v1/11752178/references?page=2